Tag: cx2018
Marc Schermerhorn: Mortality analysis of EVAS vs. EVAR
Marc Schermerhorn (Boston, USA) discusses the three-year results of an analysis on the long-term survival of Nellix EVAS system (Endologix) IDE trial patients vs....